The role of natural products as PCSK9 modulators: A review
Phytotherapy Research · 2024-08 · 38 (8) · 4081-4098
DOI: 10.1002/ptr.8260 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2024-06-20. Written by Danial Khayatan and 8 co-authors. Institution: Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Major MEDLINE topics: Proprotein Convertase 9, Biological Products, Cardiovascular Diseases, PCSK9 Inhibitors. Cited 9 times so far (Crossref); 136 references.
Abstract (original language)
A variety of mechanisms and drugs have been shown to attenuate cardiovascular disease (CVD) onset and/or progression. Recent researchers have identified a potential role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in modulating lipid metabolism and reducing plasma low density lipoprotein (LDL) levels. PCSK9 is the central protein in the metabolism of LDL cholesterol (LDL‐C) owing to its major function in LDL receptor (LDLR) degradation. Due to the close correlation of cardiovascular disease with lipid levels, many in vivo and in vitro investigations are currently underway studying the physiological role of PCSK9. Furthermore, many studies are actively investigating the mechanisms of various compounds that influence lipid associated‐disorders and their associated cardiovascular diseases. PCSK9 inhibitors have been shown to have significant impact in the prevention of emerging cardiovascular diseases. Natural products can effectively be used as PCSK9 inhibitors to control lipid levels through various mechanisms. In this review, we evaluate the role of phytochemicals and natural products in the regulation of PCSK9, and their ability to prevent cardiovascular diseases. Moreover, we describe their mechanisms of action, which have not to date been delineated.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran.
- Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran.
- Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Med…
- Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain.
ORCID profiles: Danial Khayatan, Alexandra E Butler, Tannaz Jamialahmadi, Amir Hossein Abdolghaffari, Amirhossein Sahebkar
Cite
APA
Khayatan, D., Zare, K., Khanahmadi, M., Momtaz, S., Butler, A. E., Jamialahmadi, T., Almahmeed, W., Abdolghaffari, A. H., & Sahebkar, A. (2024). The role of natural products as PCSK9 modulators: A review. Phytotherapy Research, 38(8), 4081-4098. https://doi.org/10.1002/ptr.8260
Vancouver
Khayatan D, Zare K, Khanahmadi M, Momtaz S, Butler AE, Jamialahmadi T, et al. The role of natural products as PCSK9 modulators: A review. Phytotherapy Research. 2024;38(8):4081-4098. doi:10.1002/ptr.8260
BibTeX
@article{Khayatan2024,
author = {Khayatan, Danial and Zare, Kimia and Khanahmadi, Maryam and Momtaz, Saeideh and Butler, Alexandra E and Jamialahmadi, Tannaz and Almahmeed, Wael and Abdolghaffari, Amir Hossein and Sahebkar, Amirhossein},
title = {The role of natural products as PCSK9 modulators: A review},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {8},
pages = {4081--4098},
doi = {10.1002/ptr.8260}
}
EUVIMED